4-(4-Bromophenyl)-1H-1,2,3-triazole

Catalog No. :
ACYMIF728
CAS No. :
5301-98-4
Molecular Formula :
C8H6BrN3
Molecular Weight :
224.06

IUPAC Name:4-(4-bromophenyl)-1H-1,2,3-triazole

4-(4-Bromophenyl)-1H-1,2,3-triazole structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg98%$54.00Login to see priceIn stockIn stock
1g98%$215.00Login to see priceIn stockIn stock
5g98%$1071.00Login to see priceIn stockIn stock
25g98%$4093.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-(4-Bromophenyl)-1H-1,2,3-triazole
IUPAC Name4-(4-bromophenyl)-1H-1,2,3-triazole
MDL No.MFCD06251911
Molecular FormulaC8H6BrN3
Molecular Weight224.06
SMILESBrC1=CC=C(C2=CNN=N2)C=C1
InChI KeyRYKZCPFWGNDOQV-UHFFFAOYSA-N
Synonym4-(4-bromophenyl)-1H-1,2,3-triazole | MetAP2-IN-1 | 5-(4-bromophenyl)-1H-1,2,3-triazole | 1H-1,2,3-Triazole, 4-(4-bromophenyl)- | 4-(4-bromophenyl)-2H-triazole | p-bromophenyl triazol | BDBM17460 | DTXSID10423549 | RYKZCPFWGNDOQV-UHFFFAOYSA-N | AKOS023565
CAS No.5301-98-4
PubChem CID6419341

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P264-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACYMIF728 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACYMIF728 route product structure diagram
    ACYMIF7285301-98-4 In Stock
Inquiry

2. ACYMIF728 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACYMIF728 route product structure diagram
    ACYMIF7285301-98-4 In Stock
Inquiry

Comments (0)